2017 annual financial data
Intellia Therapeutics 2017 Revenue growth
Direct answer
Revenue growth was 58.49%.
Operating income was -69,555,000 USD and net income was -67,543,000 USD.
Operating cash flow was -65,276,000 USD.
Get free Intellia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,117,000 USD
- Operating income
- -69,555,000 USD
- Net income
- -67,543,000 USD
- Operating cash flow
- -65,276,000 USD